ERBB2 and ductal breast carcinoma in situ: For instance, in DCIS, germline BRCA1 and BRCA2 mutations, HER2 amplification, and negative ER and PR status are observed, reflecting the full spectrum of luminal A, luminal B, HER2-enriched, and basal-like molecular subtypes.